Article
The primary mechanism for highly potent inhibition of HIV-1 maturation by lenacapavir
2024-12-07
Abstract excerpt
Lenacapavir (LEN) is a highly potent, long-acting antiretroviral medication for treating people infected with muti-drug-resistant HIV-1 phenotypes. The inhibitor targets multifaceted functions of the viral capsid protein (CA) during HIV-1 replication. Previous studies have mainly focused on elucidating LEN’s mode of action during viral ingress. Additionally, the inhibitor has been shown to interfere with mature ca...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 64acb508-6fa4-5f79-af32-f8e5d0a0284c
- DOI
- 10.1101/2024.12.06.627250
